دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Treatment for Alzheimer's disease: time to get ready
doi : 10.1016/S1474-4422(23)00167-9
Volume 22, Issue 6, June 2023, Page 455
Rimegepant for migraine: acute efficacy beyond the USA
Dimos D Mitsikostas
doi : 10.1016/S1474-4422(23)00160-6
Volume 22, Issue 6, June 2023, Pages 456-457
Antiplatelets for secondary stroke prevention in China
*Simiao Wu, Craig S Anderson
doi : 10.1016/S1474-4422(23)00130-8
Volume 22, Issue 6, June 2023, Pages 457-459
Valbenazine as treatment for Huntington's disease chorea
Beatrice Heim, *Klaus Seppi
doi : 10.1016/S1474-4422(23)00163-1
Volume 22, Issue 6, June 2023, Pages 459-460
Autoimmune encephalitis: chasing a moving target
*Arun Venkatesan, John C Probasco
doi : 10.1016/S1474-4422(23)00165-5
Volume 22, Issue 6, June 2023, Pages 460-462
Targeting tau degradation: a viable therapeutic approach?
Matthew Mason, Mehtap Bacioglu, Giorgio Vivacqua, Maria Grazia Spillantini, Aviva M Tolkovsky
doi : 10.1016/S1474-4422(23)00108-4
Volume 22, Issue 6, June 2023, Pages 462-464
Aspiring to restore arm and hand function after stroke
*Kathryn S Hayward, Julie Bernhardt
doi : 10.1016/S1474-4422(23)00150-3
Volume 22, Issue 6, June 2023, Pages 464-465
Boston criteria version 2.0 and non-haemorrhagic presentations
João Moura, *LuÃs F Maia
doi : 10.1016/S1474-4422(23)00161-8
Volume 22, Issue 6, June 2023, Page 466
Boston criteria version 2.0 and non-haemorrhagic presentations – Authors' reply
Andreas Charidimou, Steven M Greenberg
doi : 10.1016/S1474-4422(23)00162-X
Volume 22, Issue 6, June 2023, Pages 466-467
The Brain Research Africa Initiative (BRAIN)
Alfred K Njamnshi, Leonard Ngarka, Wepnyu Y Njamnshi, Nene Ahidjo, Joelle N Chabwine, Vladimir Hachinski, on behalf of the BRAIN-SCAN Congress 1.5 Scientific Committee and Organising Secretariat
doi : 10.1016/S1474-4422(23)00164-3
Volume 22, Issue 6, June 2023, Pages 467-468
Monomania of political strife by Géricault
Javier S Burgos
doi : 10.1016/S1474-4422(23)00159-X
Volume 22, Issue 6, June 2023, Pages 468-469
Correction to Lancet Neurol 2023; 22: 368–69
doi : 10.1016/S1474-4422(23)00173-4
Volume 22, Issue 6, June 2023, Page e8
Correction to Lancet Neurol 2023; 22: 373–74
doi : 10.1016/S1474-4422(23)00172-2
Volume 22, Issue 6, June 2023, Page e8
Correction to Lancet Neurol 2023; 22: 505–16
doi : 10.1016/S1474-4422(23)00174-6
Volume 22, Issue 6, June 2023, Page e8
Peter Goadsby: knowledge of politics, politics of knowledge
Adrian Burton
doi : 10.1016/S1474-4422(23)00168-0
Volume 22, Issue 6, June 2023, Page 470
Stroke care quality—why recognition matters
Jan Van Der Merwe
doi : 10.1016/S1474-4422(23)00175-8
Volume 22, Issue 6, June 2023, Page 471
A study in healing the wounds of trauma
Jules Morgan
doi : 10.1016/S1474-4422(23)00170-9
Volume 22, Issue 6, June 2023, Page 472
A sensitive portrayal of a controversial condition
Robert Stirrups
doi : 10.1016/S1474-4422(22)00525-7
Volume 22, Issue 6, June 2023, Page 473
Neurological research in children: challenges and misconceptions
Terry Sanger
doi : 10.1016/S1474-4422(23)00156-4
Volume 22, Issue 6, June 2023, Pages 474-475
Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial
Shengyuan Yu, Byung-Kun Kim, Aihong Guo, Man-Ho Kim, Mingjie Zhang, Zhen Wang, Jianguang Liu, Heui-Soo Moon, Ge Tan, Qian Yang, Donnie McGrath, Michael Hanna, David A Stock, Yanfei Gao, Robert Croop, Zhihong Lu
doi : 10.1016/S1474-4422(23)00126-6
Volume 22, Issue 6, June 2023, Pages 476-484
Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): a randomised, double-blind, double-dummy, active control, non-inferiority trial
Yuesong Pan*, Xia Meng*, Baoshi Yuan, S Claiborne Johnston, Hao Li, Philip M Bath, Qiang Dong, Anding Xu, Jing Jing, Jinxi Lin, Yong Jiang, Xuewei Xie, Aoming Jin, Yue Suo, Hongqin Yang, Yefang Feng, Yanhua Zhou, Qing Liu, Xueli Li, Bin Liu, Hui Zhu, Jinguo Zhao, Xuerong Huang, Haitao Li, Yunyun Xiong, Zixiao Li, Yilong Wang, Xingquan Zhao, Liping Liu, Yongjun Wang, for the INSURE Investigatorsâ€
doi : 10.1016/S1474-4422(23)00113-8
Volume 22, Issue 6, June 2023, Pages 485-493
Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial
Erin Furr Stimming, Daniel O Claassen, Elise Kayson, Jody Goldstein, Raja Mehanna, Hui Zhang, Grace S Liang, Dietrich Haubenberger, on behalf of the Huntington Study Group KINECT-HD Collaborators*
doi : 10.1016/S1474-4422(23)00127-8
Volume 22, Issue 6, June 2023, Pages 494-504
The complexities underlying epilepsy in people with glioblastoma
Elisaveta Sokolov, Jorg Dietrich, Andrew J Cole
doi : 10.1016/S1474-4422(23)00031-5
Volume 22, Issue 6, June 2023, Pages 505-516
Traumatic brain injury as a chronic disease: insights from the United States Traumatic Brain Injury Model Systems Research Program
Kristen Dams-O’Connor, Shannon B Juengst, Jennifer Bogner, Nancy D Chiaravalloti, John D Corrigan, Joseph T Giacino, Cynthia L Harrison-Felix, Jeanne M Hoffman, Jessica M Ketchum, Anthony H Lequerica, Jennifer H Marwitz, A Cate Miller, Risa Nakase-Richardson, Amanda R Rabinowitz, Angelle M Sander, Ross Zafonte, Flora M Hammond
doi : 10.1016/S1474-4422(23)00065-0
Volume 22, Issue 6, June 2023, Pages 517-528
Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease
Josep Dalmau, Francesc Graus
doi : 10.1016/S1474-4422(23)00083-2
Volume 22, Issue 6, June 2023, Pages 529-540
